Fierce Biotech November 10, 2023
Conor Hale

No, you didn’t set your clocks too far back for the end of daylight saving time. This week, the FDA granted its first full, bona fide clearance to an over-the-counter home antigen test for COVID-19, and its first to carry an official 510(k) for use in children under age 18.

Since 2020, the agency has granted emergency use authorizations to dozens of rapid, antigen-based coronavirus tests and hundreds of lab-based molecular diagnostics under its pandemic-era authorities.

And, while the U.S. government’s public health emergency declaration expired this past May, many EUAs still remain in effect. In this specific category of at-home, OTC tests, the agency currently lists 37 products with active green lights.

The Flowflex COVID-19 antigen home test, developed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article